Guan X - Search Results

1

A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV.

Guan X, Verma AK, Wang G, Roy A, Perlman S, Du L. Guan X, et al. Vaccines (Basel). 2024 Jun 1;12(6):605. doi: 10.3390/vaccines12060605. Vaccines (Basel). 2024. PMID: 38932334 Free PMC article.

2

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.

Shi J, Zheng J, Tai W, Verma AK, Zhang X, Geng Q, Wang G, Guan X, Malisheni MM, Odle AE, Zhang W, Li F, Perlman S, Du L. Shi J, et al. Among authors: guan x. J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16. J Virol. 2022. PMID: 35972290 Free PMC article.

3

mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern.

Wang G, Shi J, Verma AK, Guan X, Perlman S, Du L. Wang G, et al. Among authors: guan x. iScience. 2022 Dec 22;25(12):105690. doi: 10.1016/j.isci.2022.105690. Epub 2022 Dec 1. iScience. 2022. PMID: 36471872 Free PMC article.

4

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.

Shi J, Wang G, Zheng J, Verma AK, Guan X, Malisheni MM, Geng Q, Li F, Perlman S, Du L. Shi J, et al. Among authors: guan x. NPJ Vaccines. 2022 Dec 19;7(1):169. doi: 10.1038/s41541-022-00580-z. NPJ Vaccines. 2022. PMID: 36535987 Free PMC article.

5

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines.

Guan X, Yang Y, Du L. Guan X, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):422-439. doi: 10.1080/14760584.2023.2211153. Expert Rev Vaccines. 2023. PMID: 37161869 Free PMC article. Review.

6

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.

Tai W, Zheng J, Zhang X, Shi J, Wang G, Guan X, Zhu J, Perlman S, Du L. Tai W, et al. Among authors: guan x. Virus Res. 2023 Sep;334:199156. doi: 10.1016/j.virusres.2023.199156. Epub 2023 Jun 19. Virus Res. 2023. PMID: 37336390 Free PMC article.

7

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge.

Guan X, Verma AK, Wang G, Shi J, Perlman S, Du L. Guan X, et al. iScience. 2023 Sep 27;26(10):108033. doi: 10.1016/j.isci.2023.108033. eCollection 2023 Oct 20. iScience. 2023. PMID: 37822493 Free PMC article.

8

A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.

Shi J, Zheng J, Zhang X, Tai W, Compas R, Deno J, Jachym N, Verma AK, Wang G, Guan X, Odle AE, Wan Y, Li F, Perlman S, Qiao L, Du L. Shi J, et al. Among authors: guan x. JCI Insight. 2024 Mar 8;9(5):e155789. doi: 10.1172/jci.insight.155789. JCI Insight. 2024. PMID: 38456504 Free PMC article.

9

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV.

Wang G, Verma AK, Shi J, Guan X, Meyerholz DK, Bu F, Wen W, Liu B, Li F, Perlman S, Du L. Wang G, et al. Among authors: guan x. NPJ Vaccines. 2024 Jul 25;9(1):133. doi: 10.1038/s41541-024-00922-z. NPJ Vaccines. 2024. PMID: 39054338 Free PMC article.

10

Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.

Wang G, Verma AK, Guan X, Bu F, Odle AE, Li F, Liu B, Perlman S, Du L. Wang G, et al. Among authors: guan x. J Virol. 2024 Sep 17;98(9):e0037624. doi: 10.1128/jvi.00376-24. Epub 2024 Aug 27. J Virol. 2024. PMID: 39189731 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,526 results

Search Page

Filters